The U.S. EPA has taken steps to provide additional flexibility to manufacturers of disinfectants in an attempt to increase the availability of products for Americans to use against the novel Coronavirus. To address supply chain challenges posed by the pandemic, the EPA is allowing manufacturers to obtain certain inert ingredients, like sodium chloride or glucose, from different supplies without first checking with the agency for approval. In addition, the agency is also continuing to expedite the review of submissions from companies requesting to add viral pathogen claims to their already registered surface disinfectant labels. The agency continues to be able to approve claims within 14 days compared to the 90 day window these claims typically require.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.